Finance

Beta
Lists
688739:SHA
Liaoning Chengda Biotechnology Co Ltd
CNÂ¥19.95
-0.65%
(-0.13) 1D
Jun 12, 3:00:05 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688739...
Open
CNÂ¥20.22
High
CNÂ¥20.32
Low
CNÂ¥19.95
Mkt. cap
8.31B
Avg. vol.
2.28M
Volume
2.97M
Dividend
0.50%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Jun 3, 2026
P/E ratio
146.07
52-wk high
CNÂ¥29.63
52-wk low
CNÂ¥19.95
EPS
CNÂ¥0.14
No. of employees
2K
Open
CNÂ¥20.22
High
CNÂ¥20.32
Low
CNÂ¥19.95
Mkt. cap
8.31B
Avg. vol.
2.28M
Volume
2.97M
Dividend
0.50%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Jun 3, 2026
P/E ratio
146.07
52-wk high
CNÂ¥29.63
52-wk low
CNÂ¥19.95
EPS
CNÂ¥0.14
No. of employees
2K
News stories
From sources across the web
About Liaoning Chengda Biotechnology Co Ltd
CEO-
Employees1.78K
FoundedJun 17, 2002
Headquarters-
SectorBiotechnology
Websitecdbio.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
348.38M
389.11M
294.40M
273.35M
Cost of goods sold
74.63M
62.15M
182.56M
70.94M
Cost of revenue
74.63M
62.15M
182.56M
70.94M
Research and development expenses
69.05M
89.39M
82.63M
52.22M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
148.36M
153.51M
167.92M
142.11M
Operating expense
234.16M
238.92M
253.11M
204.38M
Total operating expenses
308.80M
301.07M
435.67M
275.32M
Operating income
39.59M
88.04M
-141.27M
-1.97M
Other non operating income
-305.06K
793.05K
-2.48M
-1.62M
EBT including unusual items
65.81M
65.19M
-41.54M
1.23M
EBT excluding unusual items
59.36M
102.13M
-140.22M
8.63M
Income tax expense
15.73M
22.67M
-8.52M
3.14M
Effective tax rate
23.91%
34.78%
20.51%
254.83%
Other operating expenses
8.15M
-5.17M
11.59M
3.29M
Net income
50.08M
42.52M
-33.02M
-1.91M
Net profit margin
14.37%
10.93%
-11.22%
-0.70%
Earnings per share
-
-
-
-
Interest and investment income
19.26M
14.42M
4.07M
12.34M
Interest expense
-160.90K
-143.49K
-953.46K
-109.82K
Net interest expenses
19.10M
14.28M
3.11M
12.23M
Depreciation and amortization charges
-
-
-
-
EBITDA
80.20M
129.29M
-98.75M
40.55M
Gain or loss from assets sale
278.06K
-278.06K
601.00
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer